Skip to content
Independent analysis of NHS open data
PharmaInsight

Nintedanib

Malignant Disease and Immunosuppression Cytotoxic drugs BNF 0801050BT
Data updated March 2026 Download CSV
2items

Dispensed in March 2026

5items

Rolling 12 months

£2,187

Net ingredient cost · March 2026

Figure 1. Nintedanib: national items dispensed by month

0 1.5 3 Jun 2021 Feb 2023 Jan 2024 Sep 2024 Jul 2025 Mar 2026 2 Jun 2021: 1 Mar 2022: 1 Dec 2022: 1 Feb 2023: 1 Nov 2023: 1 Dec 2023: 1 Jan 2024: 1 Mar 2024: 1 Jul 2024: 3 Sep 2024: 1 Nov 2024: 2 Jan 2025: 1 Jul 2025: 1 Aug 2025: 1 Sep 2025: 1 Mar 2026: 2

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV
Embed this chart

At a glance

  • Therapeutic class Cytotoxic drugs
  • Presentations 1 shown
  • Average cost / item £1,093.48
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, March 2026

The individual products dispensed under Nintedanib this month.

Presentations of Nintedanib, March 2026
Presentation BNF code Items Net ingredient cost
Ofev 100mg capsules 0801050BTBCAAAA 2 £2,187

Source: NHSBSA Prescription Cost Analysis · to March 2026 OGL v3.0

Where Nintedanib is dispensed

The regions and dispensing practices with the highest Nintedanib volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Nintedanib is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Nintedanib with

Other medicines in the same BNF section, by prescribing volume.